Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments
- 7 March 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 174 (1-2) , 147-156
- https://doi.org/10.1016/j.jneuroim.2006.01.012
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controlsJournal of Neuroimmunology, 2003
- Epitope spreading in immune-mediated diseases: implications for immunotherapyNature Reviews Immunology, 2002
- Anti-MOG and anti-MBP antibody subclasses in multiple sclerosisMultiple Sclerosis Journal, 2001
- Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regionsEuropean Journal of Immunology, 1997
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in PathogenesisBrain Pathology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controlsJournal of Neuroimmunology, 1991
- Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)Journal of Neuroimmunology, 1987
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983